Alexza Pharmaceuticals Inc.

MOUNTAIN VIEW, CA · CIK 0001344413 · Medtech

Staccato inhalation delivery system for rapid-onset pharmaceuticals

alexza.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$37M
9 Form D · Feb 2016
128 months since last filing
Contracts
—
No federal contracts on record
Patents
40
21 granted · 19 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$19,720,309
Private capital raisedForm D · SEC$1,012,500
Private capital raisedForm D · SEC$3,000,000
Private capital raisedForm D · SEC$25,000,000
Private capital raisedForm D · SEC$3,457
Private capital raisedForm D · SEC$8,000,000
Private capital raisedForm D · SEC$143,750
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
924AGITATED SOLUTIONS, LLC—$515K
925Qardio, Inc.—$39M
926ASC JV LLC—$750K
927Alexza Pharmaceuticals Inc.—$37M
928APO Technologies, Inc——
929Telcare, Inc.—$65M
930NeuroSigma, Inc.—$13M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 19 related persons
  • Hal BarronDirector
  • J BuchiDirector
  • Andrew BusserDirector
  • James CassellaExecutive Officer
  • Samuel ColellaDirector
  • Alan FrazierDirector
  • Edwin KamemotoExecutive Officer
  • Thomas KingDirector · Executive Officer
  • Robert LippeExecutive Officer
  • Darl MorelandExecutive Officer
  • August MorettiExecutive Officer
  • Mark OkiExecutive Officer
  • Deepika PakianathanDirector
  • J ReadDirector
  • Gordon RingoldDirector
  • Peter SchinellerExecutive Officer
  • Michael SimmsExecutive Officer
  • Isaac SteinDirector
  • Joseph TurnerDirector

Patents

USPTO · 21 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.